Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Why Co-Diagnostics Stock Is Getting Clobbered Today
12:18pm, Tuesday, 17'th Nov 2020
The company badly missed Wall Street earnings estimate for the third quarter.
Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests
06:30am, Tuesday, 17'th Nov 2020
SALT LAKE CITY, Nov. 17, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2020 Results - Earnings Call Transcript
10:06pm, Monday, 16'th Nov 2020
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2020 Results - Earnings Call Transcript
The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)
08:21am, Wednesday, 11'th Nov 2020
The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)
Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction
06:30am, Wednesday, 11'th Nov 2020
SALT LAKE CITY, Nov. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast
06:30am, Tuesday, 10'th Nov 2020
SALT LAKE CITY, Nov. 10, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share
04:45pm, Monday, 02'nd Nov 2020
SALT LAKE CITY, Utah, Nov. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tes
Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection
10:30am, Friday, 02'nd Oct 2020
SALT LAKE CITY, Oct. 2, 2020 /PRNewswire via COMTEX/ --
SALT LAKE CITY, Oct. 2, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular...
Pandemic Stocks Set to Thrive Again? (NASDAQ: CODX) (OTC PINK: ALST) (NASDAQ: SRNE)
12:38pm, Thursday, 01'st Oct 2020
Oct 01, 2020 (OTC PR WIRE via COMTEX) --
We have started to see spikes in Covid-19 cases in Canada, the UK, Germany, Spain, and France over the past two...
What We Learned About Co-Diagnostics' (NASDAQ:CODX) CEO Compensation
11:34am, Tuesday, 18'th Aug 2020
Dwight Egan is the CEO of Co-Diagnostics, Inc. (NASDAQ:CODX), and in this article, we analyze the executive's...
Co-Diagnostics Inc. (CODX) CEO Dwight H Egan on Q2 2020 Results - Earnings Call Transcript
07:30pm, Monday, 17'th Aug 2020
Co-Diagnostics Inc. (NASDAQ:CODX) Q2 2020 Earnings Conference Call August 13, 2020 04:30 PM ET Company Participants Andrew Benson - IR Dwight H Egan - CEO Reed Benson - CFO Conference Call Participant
Co-Diagnostics CEO on COVID-19 testing delays: We're 'not part of that log jam'
06:25pm, Monday, 17'th Aug 2020
Co-Diagnostics CEO Dwight Egan, joins Yahoo Finance's Zack Guzman to discuss the company's second-quarter earnings results, as it plans to deploy new flu and coronavirus test panels.
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of USO, CODX and GEO
06:05pm, Monday, 17'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 17, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies.
Los Angeles, California--(Newsfile Corp. - August 17, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Co-Diagnostics,
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Co-Diagnostics, Inc. (NASDAQ: CODX) between February 25, 2020 and May 15, 2020, inclusive (the "Class Period"
